Printed From BioPortfolio.com
ABUS Is Abuzz...
05:34 EDT 3 Nov 2017 | RTTNews
Shares of Arbutus Biopharma Corp. (ABUS) have gained an impressive 122% year-to-date, thanks to rising investor optimism about the Company's pipeline. Also, let's take a look at few other pharma stocks that grabbed headlines this week.
Original Article: ABUS Is Abuzz...
